News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
381,280 Results
Type
Article (18012)
Company Profile (113)
Press Release (363148)
Multimedia
Podcasts (39)
Webinars (11)
Section
Business (107340)
Career Advice (509)
Deals (19806)
Drug Delivery (70)
Drug Development (39328)
Employer Resources (60)
FDA (9451)
Job Trends (8839)
News (178634)
Policy (15855)
Tag
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (1486)
Academic (1)
Accelerated approval (15)
Adcomms (7)
Allergies (80)
Alliances (30508)
ALS (121)
Alzheimer's disease (1087)
Antibody-drug conjugate (ADC) (218)
Approvals (9852)
Artificial intelligence (348)
Autoimmune disease (98)
Automation (35)
Bankruptcy (109)
Best Places to Work (7303)
BIOSECURE Act (11)
Biosimilars (138)
Biotechnology (63)
Bladder cancer (100)
Brain cancer (29)
Breast cancer (409)
Cancer (2991)
Cardiovascular disease (274)
Career advice (461)
Career pathing (11)
CAR-T (157)
CDC (6)
Celiac Disease (1)
Cell therapy (434)
Cervical cancer (23)
Clinical research (35306)
Collaboration (1343)
Company closure (1)
Compensation (528)
Complete response letters (22)
COVID-19 (1706)
CRISPR (56)
C-suite (639)
Cystic fibrosis (75)
Data (4051)
Denatured (26)
Depression (78)
Diabetes (307)
Diagnostics (5175)
Digital health (37)
Diversity (5)
Diversity, equity & inclusion (16)
Drug discovery (167)
Drug pricing (47)
Drug shortages (13)
Duchenne muscular dystrophy (123)
Earnings (39558)
Editorial (21)
Employer branding (11)
Employer resources (53)
Events (60223)
Executive appointments (720)
FDA (11602)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (2)
Frontotemporal dementia (9)
Funding (890)
Gene editing (120)
Generative AI (30)
Gene therapy (386)
GLP-1 (529)
Government (2199)
Grass and pollen (6)
Guidances (283)
Healthcare (10089)
HIV (45)
Huntington's disease (18)
IgA nephropathy (62)
Immunology and inflammation (122)
Immuno-oncology (33)
Indications (91)
Infectious disease (1900)
Inflammatory bowel disease (119)
Inflation Reduction Act (1)
Influenza (87)
Intellectual property (170)
Interviews (63)
IPO (8782)
IRA (15)
Job creations (1900)
Job search strategy (419)
JPM (29)
Kidney cancer (9)
Labor market (29)
Layoffs (216)
Leadership (11)
Legal (2887)
Liver cancer (54)
Longevity (6)
Lung cancer (470)
Lymphoma (257)
Machine learning (21)
Management (17)
Manufacturing (577)
MASH (107)
Medical device (7889)
Medtech (7916)
Mergers & acquisitions (11781)
Metabolic disorders (715)
Multiple sclerosis (121)
NASH (12)
Neurodegenerative disease (200)
Neuropsychiatric disorders (49)
Neuroscience (1902)
Neurotech (1)
NextGen: Class of 2026 (2802)
Non-profit (2329)
Now hiring (34)
Obesity (291)
Opinion (109)
Ovarian cancer (77)
Pain (110)
Pancreatic cancer (116)
Parkinson's disease (182)
Partnered (23)
Patents (293)
Patient recruitment (306)
Peanut (33)
People (35336)
Pharmaceutical (32)
Pharmacy benefit managers (3)
Phase 1 (9284)
Phase 2 (14516)
Phase 3 (14115)
Pipeline (3735)
Policy (89)
Postmarket research (1309)
Preclinical (3487)
Press Release (61)
Prostate cancer (145)
Psychedelics (16)
Radiopharmaceuticals (184)
Rare diseases (475)
Real estate (4200)
Recruiting (24)
Regulatory (13601)
Reports (21)
Research institute (1535)
Resumes & cover letters (60)
Rett syndrome (23)
RNA editing (5)
RSV (48)
Schizophrenia (114)
Series A (143)
Series B (121)
Service/supplier (3)
Sickle cell disease (58)
Special edition (5)
Spinal muscular atrophy (114)
Sponsored (27)
Startups (1780)
State (1)
Stomach cancer (9)
Supply chain (76)
Tariffs (24)
The Weekly (13)
Vaccines (608)
Venture capital (36)
Weight loss (158)
Women's health (54)
Worklife (2)
Date
Today (15)
Last 7 days (401)
Last 30 days (1292)
Last 365 days (19126)
2026 (2197)
2025 (19299)
2024 (21494)
2023 (23967)
2022 (33555)
2021 (36124)
2020 (34167)
2019 (25937)
2018 (19617)
2017 (18152)
2016 (17517)
2015 (19975)
2014 (14799)
2013 (12130)
2012 (13099)
2011 (12920)
2010 (11379)
Location
Africa (411)
Alabama (35)
Alaska (5)
Arizona (128)
Arkansas (8)
Asia (27324)
Australia (4520)
California (6352)
Canada (1823)
China (1018)
Colorado (252)
Connecticut (256)
Delaware (262)
Europe (58800)
Florida (985)
Georgia (202)
Hawaii (3)
Idaho (31)
Illinois (491)
India (65)
Indiana (408)
Iowa (9)
Japan (399)
Kansas (58)
Kentucky (20)
Louisiana (11)
Maine (37)
Maryland (774)
Massachusetts (5043)
Michigan (246)
Minnesota (318)
Mississippi (4)
Missouri (101)
Montana (22)
Nebraska (11)
Nevada (74)
New Hampshire (60)
New Jersey (2239)
New Mexico (17)
New York (1916)
North Carolina (956)
North Dakota (8)
Northern California (3060)
Ohio (252)
Oklahoma (10)
Oregon (16)
Pennsylvania (1346)
Puerto Rico (15)
Rhode Island (28)
South America (639)
South Carolina (22)
Southern California (2528)
Tennessee (99)
Texas (1030)
United States (24259)
Utah (203)
Virginia (136)
Washington D.C. (43)
Washington State (526)
West Virginia (2)
Wisconsin (75)
Wyoming (2)
381,280 Results for "acm global central laboratory".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors
October 22, 2025
·
2 min read
Press Releases
Frontage Laboratories Expands Early Phase Clinical Capabilities to Support Global Drug Development
February 1, 2026
·
2 min read
Press Releases
AI-Powered R&D Acceleration: Insilico Medicine and CMS announce multiple collaborations in central nervous system and autoimmune diseases
February 10, 2026
·
5 min read
Press Releases
Helsinn and MagnaPharm enter long-term agreement for AKYNZEO® and ALOXI® across five Central and Eastern European countries
February 11, 2026
·
4 min read
Press Releases
FDA Approves Label Update for Kite’s Yescarta® for Relapsed/Refractory Primary Central Nervous System Lymphoma
February 8, 2026
·
18 min read
Press Releases
Daiichi Sankyo and GENESIS Pharma Enter Exclusive Agreement for VANFLYTA® Commercialization in Central and Eastern Europe
January 7, 2026
·
4 min read
Press Releases
Charles River Laboratories to Present at Jefferies Global Healthcare Conference 2025
November 18, 2025
·
1 min read
Press Releases
Rentschler Biopharma Inc. named Manufacturer of the Year for Central Massachusetts
October 24, 2025
·
4 min read
Press Releases
Precision for Medicine Broadens Global Footprint with Singapore Office Opening
February 5, 2026
·
3 min read
Press Releases
Exousia Pro, Inc. Completes Exclusive Licensing Agreement With the University of Central Florida for Novel Cancer Diagnostic and Therapy Platforms
December 3, 2025
·
4 min read
1 of 38,128
Next
